Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Treace Medical Concepts Q3 EPS $(0.26) Beats $(0.28) Estimate, Sales $50.214M Beat $49.732M Estimate

Author: Benzinga Newsdesk | November 06, 2025 04:10pm
Treace Medical Concepts (NASDAQ:TMCI) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.28) by 7.14 percent. This is a 4 percent decrease over losses of $(0.25) per share from the same period last year. The company reported quarterly sales of $50.214 million which beat the analyst consensus estimate of $49.732 million by 0.97 percent. This is a 11.37 percent increase over sales of $45.086 million the same period last year.

Posted In: TMCI


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist